203 related articles for article (PubMed ID: 27039780)
1. Assessing the EORTC QLQ-BM22 Module Using Rasch Modeling and Confirmatory Factor Analysis across Countries: a Comprehensive Psychometric Evaluation in Patients with Bone Metastases.
Lin CY; Pakpour AH
Asian Pac J Cancer Prev; 2016; 17(3):1405-10. PubMed ID: 27039780
[TBL] [Abstract][Full Text] [Related]
2. International field testing of the reliability and validity of the EORTC QLQ-BM22 module to assess health-related quality of life in patients with bone metastases.
Chow E; Nguyen J; Zhang L; Tseng LM; Hou MF; Fairchild A; Vassiliou V; Jesus-Garcia R; Alm El-Din MA; Kumar A; Forges F; Chie WC; Bottomley A;
Cancer; 2012 Mar; 118(5):1457-65. PubMed ID: 21837676
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the EORTC QLQ-BM22 and the BOMET-QOL quality of life questionnaires in patients with bone metastases.
Bedard G; Zeng L; Poon M; Lam H; Lauzon N; Chow E
Asia Pac J Clin Oncol; 2014 Jun; 10(2):118-23. PubMed ID: 23551978
[TBL] [Abstract][Full Text] [Related]
4. The European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire for patients with bone metastases: the EORTC QLQ-BM22.
Chow E; Hird A; Velikova G; Johnson C; Dewolf L; Bezjak A; Wu J; Shafiq J; Sezer O; Kardamakis D; van der Linden Y; Ma B; Castro M; Arnalot PF; Ahmedzai S; Clemons M; Hoskin P; Yee A; Brundage M; Bottomley A;
Eur J Cancer; 2009 May; 45(7):1146-1152. PubMed ID: 19097882
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the EORTC QLQ-BM22 and the FACT-BP for assessment of quality of life in cancer patients with bone metastases.
Popovic M; Nguyen J; Chen E; Di Giovanni J; Zeng L; Chow E
Expert Rev Pharmacoecon Outcomes Res; 2012 Apr; 12(2):213-9. PubMed ID: 22458622
[TBL] [Abstract][Full Text] [Related]
6. The reliability and validity of the Iranian version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire for patients with Bone Metastases: the EORTC QLQ-BM22.
Yekaninejad MS; Ahmadzadeh A; Mosavi SH; Saffari M; Pakpour AH; Tolooei F; Chow E; Bottomley A
Expert Rev Pharmacoecon Outcomes Res; 2014 Feb; 14(1):147-56. PubMed ID: 24328844
[TBL] [Abstract][Full Text] [Related]
7. A brief instrument to measure health-related quality-of-life in patients with bone metastasis: validation of the German version of Bone Metastases Quality-of-Life-10 (BOMET-QoL-10).
Marschner N; Wilke J; Reschke D; Kaiser F; Schmoor C; Grugel R; Boller E
J Med Econ; 2018 Sep; 21(9):920-929. PubMed ID: 29874105
[TBL] [Abstract][Full Text] [Related]
8. Psychometric properties of the updated EORTC module for assessing quality of life in patients with lung cancer (QLQ-LC29): an international, observational field study.
Koller M; Shamieh O; Hjermstad MJ; Hornslien K; Young T; Chalk T; Ioannidis G; Harle A; Johnson CD; Tomaszewski KA; Serpentini S; Pinto M; van der Weijst L; Janssens A; Morag O; Chie WC; Arraras JI; Pompili C; Jungraithmayr W; Hechtner M; Katsochi D; Müller K; Gräfenstein L; Schulz C; Bottomley A; ; ;
Lancet Oncol; 2020 May; 21(5):723-732. PubMed ID: 32213338
[TBL] [Abstract][Full Text] [Related]
9. A prospective study validating the EORTC QLQ-BM22 bone metastases module in patients with painful bone metastases undergoing palliative radiotherapy.
Raman S; Ding K; Chow E; Meyer RM; Nabid A; Chabot P; Coulombe G; Ahmed S; Kuk J; Dar AR; Mahmud A; Fairchild A; Wilson CF; Wu JS; Dennis K; DeAngelis C; Wong RK; Zhu L; Brundage M
Radiother Oncol; 2016 May; 119(2):208-12. PubMed ID: 27157890
[TBL] [Abstract][Full Text] [Related]
10. An international prospective study establishing minimal clinically important differences in the EORTC QLQ-BM22 and QLQ-C30 in cancer patients with bone metastases.
Zeng L; Chow E; Zhang L; Tseng LM; Hou MF; Fairchild A; Vassiliou V; Jesus-Garcia R; Alm El-Din MA; Kumar A; Forges F; Chie WC; Bedard G; Bottomley A
Support Care Cancer; 2012 Dec; 20(12):3307-13. PubMed ID: 22562607
[TBL] [Abstract][Full Text] [Related]
11. Validation of the Polish version of the EORTC QLQ-BM22 module for the assessment of health-related quality of life in patients with bone metastases.
Püsküllüoğlu M; Tomaszewski KA; Bottomley A; Holden L; Tomaszewska IM; Głowacki R; Bereza K; Golec EB; Chow E; Krzemieniecki K
Qual Life Res; 2014 Mar; 23(2):527-32. PubMed ID: 23912854
[TBL] [Abstract][Full Text] [Related]
12. [The European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire for Japanese patients with bone metastases--The Japanese version of the EORTC QLQ-BM22].
Satoh T; Kobayashi K; Hori T; Iida S; Sato A; Ishiguro H; Chow E; Shimozuma K
Gan To Kagaku Ryoho; 2010 Aug; 37(8):1507-12. PubMed ID: 20716876
[TBL] [Abstract][Full Text] [Related]
13. Understanding the EORTC QLQ-BM22, the module for patients with bone metastases.
Chow E; Bottomley A
Expert Rev Pharmacoecon Outcomes Res; 2009 Oct; 9(5):461-5. PubMed ID: 19817529
[TBL] [Abstract][Full Text] [Related]
14. The EORTC CAT Core-The computer adaptive version of the EORTC QLQ-C30 questionnaire.
Petersen MA; Aaronson NK; Arraras JI; Chie WC; Conroy T; Costantini A; Dirven L; Fayers P; Gamper EM; Giesinger JM; Habets EJJ; Hammerlid E; Helbostad J; Hjermstad MJ; Holzner B; Johnson C; Kemmler G; King MT; Kaasa S; Loge JH; Reijneveld JC; Singer S; Taphoorn MJB; Thamsborg LH; Tomaszewski KA; Velikova G; Verdonck-de Leeuw IM; Young T; Groenvold M;
Eur J Cancer; 2018 Sep; 100():8-16. PubMed ID: 29936066
[TBL] [Abstract][Full Text] [Related]
15. Validation of the Chinese version of EORTC QLQ-BM22 in patients with bone metastases.
Zhang L; Su YJ; Chen JY; Liao ZC; Luo ZQ; Xie SM; Zhang J; Lin YS; Guo H; Sun WL; Pekbay B; Miller AR; Luo L; Rui YH; Li MH; Wang CL
Support Care Cancer; 2016 Mar; 24(3):1019-24. PubMed ID: 26245496
[TBL] [Abstract][Full Text] [Related]
16. International Psychometric Validation of an EORTC Quality of Life Module Measuring Cancer Related Fatigue (EORTC QLQ-FA12).
Weis J; Tomaszewski KA; Hammerlid E; Ignacio Arraras J; Conroy T; Lanceley A; Schmidt H; Wirtz M; Singer S; Pinto M; Alm El-Din M; Compter I; Holzner B; Hofmeister D; Chie WC; Czeladzki M; Harle A; Jones L; Ritter S; Flechtner HH; Bottomley A;
J Natl Cancer Inst; 2017 May; 109(5):. PubMed ID: 28376231
[TBL] [Abstract][Full Text] [Related]
17. Quality of life in responders after palliative radiation therapy for painful bone metastases using EORTC QLQ-C30 and EORTC QLQ-BM22: results of a Brazilian cohort.
Mendez LC; Raman S; Wan BA; da Silva JLP; Moraes FY; Lima KMLB; Silva MF; Diz MDPE; Chow E; Marta GN
Ann Palliat Med; 2017 Aug; 6(Suppl 1):S65-S70. PubMed ID: 28595442
[TBL] [Abstract][Full Text] [Related]
18. Rasch model-based testing of the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire-Chemotherapy-Induced Peripheral Neuropathy (QLQ-CIPN20) using Alliance for Clinical Trials in Oncology (Alliance) A151408 study data.
Smith EML; Zanville N; Kanzawa-Lee G; Donohoe C; Bridges C; Loprinzi C; Le-Rademacher J; Yang JJ
Support Care Cancer; 2019 Jul; 27(7):2599-2608. PubMed ID: 30460399
[TBL] [Abstract][Full Text] [Related]
19. Psychometric validation of the Persian Bergen Social Media Addiction Scale using classic test theory and Rasch models.
Lin CY; Broström A; Nilsen P; Griffiths MD; Pakpour AH
J Behav Addict; 2017 Dec; 6(4):620-629. PubMed ID: 29130330
[TBL] [Abstract][Full Text] [Related]
20. Minimal clinically important differences in the EORTC QLQ-BM22 and EORTC QLQ-C15-PAL modules in patients with bone metastases undergoing palliative radiotherapy.
Raman S; Ding K; Chow E; Meyer RM; Nabid A; Chabot P; Coulombe G; Ahmed S; Kuk J; Dar AR; Mahmud A; Fairchild A; Wilson CF; Wu JSY; Dennis K; DeAngelis C; Wong RKS; Zhu L; Brundage M
Qual Life Res; 2016 Oct; 25(10):2535-2541. PubMed ID: 27138964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
